12 Alva Street, EH2 4QG Edinburgh
United Kingdom of Great Britain and Northern Ireland
Telephone +44 131 6535465
info@manusneuro.com
http://manusneuro.com
Product Categories
Product categories
01 Electromedical Equipment / Medical Technology
01.01 Diagnostics
01.01.06 Neurological diagnosis, apparatus and instruments
Neurological diagnosis, apparatus and instruments
Our products
Product category: Neurological diagnosis, apparatus and instruments
neuromotor pen
Early diagnosis and timely access to specialist care is essential for patients with Parkinson’s disease. Typically 70% of the economic burden of Parkinson’s disease is related to long-term disability.
Early detection will yield better outcomes
If early deterioration can be avoided, long-term outcomes will be better and pre-symptomatic screening will become increasingly important when neuroprotective or regenerative therapies become widely available within the next 2-5 years.
Current diagnostic methods for Parkinson’s disease are based on the clinician’s subjective interpretation. Even for experienced clinicians, differentiating between a Parkinson’s disease tremor and other tremors, such as an essential tremor can be difficult and an unequivocal diagnosis of Parkinson’s disease cannot always be made.
In such cases, neuroimaging techniques (DaTSCAN) are required, which are expensive, require skilled operators and can be unpleasant for patients. Other methods for analysis of neurophysiological signals are impractical and no reliable comparison can be made from interpretations of observations and histories that were taken by different physicians or at different points in time and the assessment is not objective.
The NeuroMotor Pen can increase the certainty of diagnosis by recognising differential diagnostic and disease progression biomarkers of Parkinson’s disease. The results will non-invasively differentiate between Parkinson’s disease and other neuromotor impairments such as essential tremor or signs of normal ageing which may mimic the symptoms of Parkinson’s disease.
Regular use of the NeuroMotor Pen enables the clinician to monitor the patient’s response to medication and disease progression.
ad: contact information
LumiraDxLuxfer Gas Cylinders Ltd.
Malem Medical Ltd.
Marsden Weighing Machine Group Limited
SOE Health Ltd
Sony Europe B.V.